Japan Atherosclerosis Society Cohort Study
- Conditions
- Dyslipidemia
- Registration Number
- JPRN-UMIN000018747
- Lead Sponsor
- JAS Cohort Study group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 1582
Not provided
1.Participants with familiar hypercholesterolemia, familial type III hyperlipidemia, and primary hyperchylomicronemia 2.Past history of stroke 3.Participants who are pregnant or lactating or intend to become pregnant 4.Participants with liver cirrhosis 5.Participants who were diagnosed as hyperthyroidism or hypothyroidism or stable at least 3 months by the treatment before entry 6.Participants who have experienced major surgery within the last 30 days 7.Participants who are currently receiving with oral retinoid agent for acne or psoriasis, systemic corticosteroids, or cyclosporine 8.Participants treated with anti-obesity drugs within the last 3 months 9.Participants who participated in the clinical trial or have been administed any investigational drug within the past 3 months, or the medical equipment 10.Participants who have received or a plan for a bariatric surgery for weight loss (gastric bypass, etc.) 11.Participants who are found to be HIV seropositive 12.Participants who have cancer, except for receiving the appropriate treatment for the localized basal cell skin cancer or mucosa in cervical cancer, or a history of cancer within the past 5 years 13.Participants with geographic elements or social element to limit the participation during the study period (including a transfer), or it is to be expected 14.Participants who are inadequate to enroll the study determined by the research doctor
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.Survey of Dyslipidemia treatment agents and the achievement of the Lipid Management Target Level of management category in the JAS Guidelines for the Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases in Japan-2012 Version 2.Relationships among cardiovascular events, dyslipidemia treatment agents, and the achievement of the Lipid Management Target Level of management category in the JAS Guidelines for the Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases in Japan-2012 Version
- Secondary Outcome Measures
Name Time Method on-fatal myocardial infarction and unstable angina Non-fatal stroke Coronary intervention Atrial fibrillation Death of cardiovascular cause Death of non-cardiovascular cause